RTP Mobile Logo

Friday, January 18, 2019, San Francisco, California, 6:45 PM – 9:00 PM

Meet The Professors: Clinical Investigator Perspectives on Key Questions and Emerging Research in the Management of Colorectal, Gastric and Hepatocellular Cancer

Event Details

Location:
San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103
Hotel Phone: (415) 896-1600

Time:
6:30 PM – 6:45 PM — Registration
6:45 PM – 9:00 PM — Educational Dinner Meeting

Meeting Room:
Yerba Buena Ballroom, Salon 9-15 (Lower B2 Level)

There is no registration fee for this event. However, preregistration is advised as seating is limited.

Faculty:
Ghassan Abou-Alfa, MD
Associate Professor
Memorial Sloan Kettering Cancer Center
New York, New York

David H Ilson, MD, PhD
Professor of Medicine
Weill Cornell Medical College
Attending Physician, Memorial Hospital
Memorial Sloan Kettering Cancer Center
New York, New York

Eric Van Cutsem, MD, PhD
Professor of Medicine
Digestive Oncology
University Hospital Gasthuisberg/Leuven
Leuven, Belgium

Additional faculty to be announced




Moderator:
Neil Love, MD
Research To Practice
Miami, Florida

Not an official event of the 2019 Gastrointestinal Cancers Symposium. Not sponsored, endorsed, or accredited by any of the cosponsoring organizations of the 2019 Gastrointestinal Cancers Symposium.

Agenda

6:30 PM – 6:45 PM — Registration
6:45 PM – 9:00 PM — Educational Dinner Meeting

Overview
This symposium will be segmented into three separate content modules, each focused on a different gastrointestinal (GI) malignancy, including colorectal, gastric and hepatocellular cancer. For each module, the meeting moderator, Dr Neil Love, will be joined on stage by two clinical investigator faculty members. No didactic lectures will be utilized. Instead Dr Love will lead an approximately 45-minute panel discussion during which the faculty members will review published clinical trial data, highlight ongoing research studies and present cases from their practices to illustrate the optimal application of the information introduced. Supporting data slides developed by Research To Practice will be integrated into the discussion. To make the program more interactive, clinician attendees will use iPads® to participate in a premeeting survey focused on the cases and topics presented, and the results will be interspersed throughout each module to foster additional debate. Detailed agenda to be announced by mid-December.

CE Information

Target Audience:
This activity is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers.

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Review recent therapeutic advances and new FDA authorizations for patients with newly diagnosed and relapsed/recurrent metastatic colorectal, gastric and hepatocellular cancer, and integrate this information, as appropriate, into routine clinical practice.
  • Appreciate available Phase III data with and consider the potential clinical roles of a number of novel agents (eg, cabozantinib, ramucirumab, TAS-102, etc) that may soon provide additional treatment options to patients with diseases beyond those for which they were initially indicated.
  • Recall the biologic rationale for, published research data with and ongoing research efforts evaluating the use of immune checkpoint inhibitors alone or in combination with chemotherapy, targeted agents or other immunotherapies in the management of patients with colorectal, gastric and hepatocellular cancers, and identify individuals who may be eligible for this strategy as part or outside of a protocol setting.
  • Describe ongoing research to validate or identify additional biomarkers predictive of response to anti-PD-1/PD-L1 antibodies in patients with gastrointestinal cancers, and use this information to guide future trial design or routine clinical practice.
  • Design and implement a plan of care to recognize and manage side effects and toxicities associated with the use of novel and recently approved systemic therapies for the management of locally advanced or metastatic colorectal, gastric and hepatocellular cancer to support quality of life and continuation of therapy.
  • Recall available and emerging data with other investigational agents currently in clinical testing for colorectal, gastric and hepatocellular cancer and, where applicable, refer eligible patients for trial participation or other expanded access programs.

CME Credit Form:
A CME credit form will be given to each participant at the conclusion of the activity.

Accreditation Statement:
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement:
Research To Practice designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy:
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.

Supporters:
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Eisai Inc, Genentech, Lilly, Merck and Taiho Oncology Inc.

Location

San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103
Hotel Phone: (415) 896-1600

Meeting Room:
Yerba Buena Ballroom, Salon 9-15 (Lower B2 Level)

Directions:
The San Francisco Marriott Marquis is located just 2 blocks (less than 0.2 miles) from the Moscone Convention Center where the 2019 Gastrointestinal Cancers Symposium is taking place.

 

Registration

This activity is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers.

There is no registration fee for this event. However, preregistration is advised as seating is limited.

Registration for clinicians in practice

I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer.

Registration for clinicians in practice »
 
Registration for other/industry professionals*

Please note, a limited number of seats are currently available for nonclinicians on a first come, first served basis.

Registration for other/industry professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating, please check in at our onsite registration desk at least one half hour prior to the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future CME programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.